Drug recall

Direct Bilirubin Reagents (DBIL 2 x 200) and (DBIL 2 x 300), Ref:439715 (200 tests/cartridge) and 476856 (300…

FDA recall event 84832 · Class II · Beckman Coulter Inc

Key facts

Event ID 84832
Recall numbers Z-1422-2020, Z-1423-2020, Z-1424-2020, Z-1425-2020, Z-1426-2020
Recalling firm Beckman Coulter Inc
Product type Devices
Products Direct Bilirubin Reagents (DBIL 2 x 200 ) and (DBIL 2 x 300), Ref:439715 (200 tests/cartridge) and 476856 (300 tests/cartridge), For In Vitro Diagnostic Use, Rx Only, UDI: 15099590575120(200…, Enzymatic Creatinine Reagent (CR-E 2 X 200), REF A60298, For in Vitro Diagnostic Use, Rx Only, UDI: 15099590625733, Total Bilirubin Reagent (TBIL 2 x 300 ) and (TBIL 2 x 400), Ref:442745 (300 tests/cartridge) and 476861 (400 tests/cartridge), For In Vitro Diagnostic Use, Rx Only, UDI: 15099590233075 (300…, Triglycerides Reagent (TG 2 x 300), REF: 445850, For In Vitro Diagnostic Use, Rx Only, UDI: 15099590233228, Uric Acid Reagent (URIC 2 X 300), REF: 442785, For In Vitro Diagnostic Use, Rx Only, UDI: 15099590575281
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall It has been determined that N-acetyl p benzoquinone imine (NAPQI), a metabolite of acetaminophen (paracetamol), may cause negative interference for assays if present in high quantities in serum due to…
Initiation date Aug 15, 2019
Report date Mar 11, 2020
Termination date Feb 28, 2024
City Carlsbad
State CA
Country United States
FEI number 2050010

At a glance

  • 1–9 Products in this recall
  • 1–9 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date:

Browse all FDA drug and product recalls